{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:16:08Z","timestamp":1791094568760,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#R01-AI125421-01A1"],"award-info":[{"award-number":["#R01-AI125421-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#R01-AI125421-01A1"],"award-info":[{"award-number":["#R01-AI125421-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#R01-AI125421-01A1"],"award-info":[{"award-number":["#R01-AI125421-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#R01-AI125421-01A1"],"award-info":[{"award-number":["#R01-AI125421-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#R01-AI125421-01A1"],"award-info":[{"award-number":["#R01-AI125421-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#R01-AI125421-01A1"],"award-info":[{"award-number":["#R01-AI125421-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#R01-AI125421-01A1"],"award-info":[{"award-number":["#R01-AI125421-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#R01-AI125421-01A1"],"award-info":[{"award-number":["#R01-AI125421-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#R01-AI125421-01A1"],"award-info":[{"award-number":["#R01-AI125421-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#R01-AI125421-01A1"],"award-info":[{"award-number":["#R01-AI125421-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#R01-AI125421-01A1"],"award-info":[{"award-number":["#R01-AI125421-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-024-01054-0","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:07:42Z","timestamp":1736899662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Rational selection of TbpB variants yields a bivalent vaccine with broad coverage against Neisseria gonorrhoeae"],"prefix":"10.1038","volume":"10","author":[{"given":"Jamie E.","family":"Fegan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Epshita A.","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixon","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie Y. T.","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa G.","family":"Currie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Zeppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony B.","family":"Schryvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor F.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Gray-Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"1054_CR1","doi-asserted-by":"crossref","unstructured":"Unemo, M., Golparian, D. & Eyre, D. W. Antimicrobial resistance in Neisseria gonorrhoeae and treatment of gonorrhea. In Methods in Molecular Biology 37\u201358 (Humana, New York, NY, 2019).","DOI":"10.1007\/978-1-4939-9496-0_3"},{"key":"1054_CR2","doi-asserted-by":"publisher","first-page":"1800323","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800323","volume":"23","author":"DW Eyre","year":"2018","unstructured":"Eyre, D. W. et al. Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Eurosurveillance 23, 1800323 (2018).","journal-title":"Eurosurveillance"},{"key":"1054_CR3","doi-asserted-by":"publisher","first-page":"2200455","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200455","volume":"27","author":"S Pleininger","year":"2022","unstructured":"Pleininger, S. et al. Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022. Eurosurveillance 27, 2200455 (2022).","journal-title":"Eurosurveillance"},{"key":"1054_CR4","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","volume":"390","author":"H Petousis-Harris","year":"2017","unstructured":"Petousis-Harris, H. et al. Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. Lancet 390, 1603\u20131610 (2017).","journal-title":"Lancet"},{"key":"1054_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008602","volume":"16","author":"I Leduc","year":"2020","unstructured":"Leduc, I. et al. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae. PLoS Pathog. 16, e1008602 (2020).","journal-title":"PLoS Pathog."},{"key":"1054_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jinf.2023.05.021","volume":"87","author":"B Wang","year":"2023","unstructured":"Wang, B. et al. 4CMenB sustained vaccine effectiveness against invasive meningococcal B disease and gonorrhoea at three years post programme implementation. J. Infect. 87, 95\u2013102 (2023).","journal-title":"J. Infect."},{"key":"1054_CR7","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S1473-3099(21)00754-4","volume":"22","author":"B Wang","year":"2022","unstructured":"Wang, B. et al. Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study. Lancet Infect. Dis. 22, 1011\u20131020 (2022). 1474-4457 (Electronic).","journal-title":"Lancet Infect. Dis."},{"key":"1054_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/0264-410X(91)90147-X","volume":"9","author":"JW Boslego","year":"1991","unstructured":"Boslego, J. W. et al. Efficacy trial of a parenteral gonococcal pilus vaccine in men. Vaccine 9, 154\u2013162 (1991).","journal-title":"Vaccine"},{"key":"1054_CR9","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1128\/jb.176.11.3162-3170.1994","volume":"176","author":"JE Anderson","year":"1994","unstructured":"Anderson, J. E., Sparling, P. F. & Cornelissen, C. N. Gonococcal transferrin-binding protein 2 facilitates but is not essential for transferrin utilization. J. Bacteriol. 176, 3162\u20133170 (1994).","journal-title":"J. Bacteriol."},{"key":"1054_CR10","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1128\/jb.178.5.1437-1444.1996","volume":"178","author":"CN Cornelissen","year":"1996","unstructured":"Cornelissen, C. N. & Sparling, P. F. Binding and surface exposure characteristics of the gonococcal transferrin receptor are dependent on both transferrin binding proteins. J. Bacteriol. 178, 1437\u20131444 (1996).","journal-title":"J. Bacteriol."},{"key":"1054_CR11","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1046\/j.1365-2958.2003.03496.x","volume":"48","author":"JE Anderson","year":"2003","unstructured":"Anderson, J. E., Hobbs, M. M., Biswas, G. D. & Sparling, P. F. Opposing selective forces for expression of the gonococcal lactoferrin receptor. Mol. Microbiol. 48, 1325\u20131337 (2003).","journal-title":"Mol. Microbiol."},{"key":"1054_CR12","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1046\/j.1365-2958.1998.00710.x","volume":"27","author":"CN Cornelissen","year":"1998","unstructured":"Cornelissen, C. N. et al. The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers. Mol. Microbiol. 27, 611\u2013616 (1998).","journal-title":"Mol. Microbiol."},{"key":"1054_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mbo3.254","volume":"4","author":"P Adamiak","year":"2015","unstructured":"Adamiak, P., Calmettes, C., Moraes, T. F. & Schryvers, A. B. Patterns of structural and sequence variation within isotype lineages of the Neisseria meningitidis transferrin receptor system. Microbiol. Open 4, 1\u201314 (2015).","journal-title":"Microbiol. Open"},{"key":"1054_CR14","doi-asserted-by":"publisher","first-page":"e00977","DOI":"10.1128\/mSphere.00977-20","volume":"6","author":"BI Baarda","year":"2021","unstructured":"Baarda, B. I., Zielke, R. A., Holm, A. K. & Sikora, A. E. Comprehensive bioinformatic assessments of the variability of Neisseria gonorrhoeae vaccine candidates. mSphere 6, e00977\u201300920 (2021).","journal-title":"mSphere"},{"key":"1054_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-8-66","volume":"8","author":"OB Harrison","year":"2008","unstructured":"Harrison, O. B., Maiden, M. C. & Rokbi, B. Distribution of transferrin binding protein B gene (tbpB) variants among Neisseria species. BMC Microbiol. 8, 66 (2008).","journal-title":"BMC Microbiol."},{"key":"1054_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1128\/iai.65.1.55-63.1997","volume":"65","author":"B Rokbi","year":"1997","unstructured":"Rokbi, B. et al. Evaluation of recombinant transferrin binding protein B variants from Neisseria meningitidis for their ability of induce cross reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains. Infect. Immun. 65, 55\u201363 (1997).","journal-title":"Infect. Immun."},{"key":"1054_CR17","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1128\/IAI.68.9.4938-4947.2000","volume":"68","author":"B Rokbi","year":"2000","unstructured":"Rokbi, B. et al. Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine. Infect. Immun. 68, 4938\u20134947 (2000).","journal-title":"Infect. Immun."},{"key":"1054_CR18","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nsmb.2251","volume":"19","author":"C Calmettes","year":"2012","unstructured":"Calmettes, C., Alcantara, J., Schryvers, A. B. & Moraes, T. F. The structural basis of transferrin iron sequestration by transferrin binding protein B. Nat. Struct. Mol. Biol. 19, 358\u2013360 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1054_CR19","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/j.1365-2958.2010.07289.x","volume":"77","author":"JM Ling","year":"2010","unstructured":"Ling, J. M., Shima, C. H., Schriemer, D. C. & Schryvers, A. B. Delineating the regions of human transferrin involved in interactions with transferrin binding protein B from Neisseria meningitidis. Mol. Microbiol. 77, 1301\u20131314 (2010).","journal-title":"Mol. Microbiol."},{"key":"1054_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1006\/mpat.1998.0226","volume":"25","author":"MD Retzer","year":"1998","unstructured":"Retzer, M. D., Yu, R.-H., Zhang, Y., Gonzalez, G. C. & Schryvers, A. B. Discrimination between apo and iron-loaded forms of transferrin by transferrin binding protein B and its N-terminal subfragment. Microb. Pathog. 25, 175\u2013180 (1998).","journal-title":"Microb. Pathog."},{"key":"1054_CR21","doi-asserted-by":"crossref","unstructured":"Fegan, J. E. et al. Utility of hybrid transferrin binding protein antigens for protection against pathogenic Neisseria species. Front. Immunol. 10: eCollection (2019).","DOI":"10.3389\/fimmu.2019.00247"},{"key":"1054_CR22","unstructured":"Curran, D. Navargator (accessed 2 March 2023); https:\/\/www.compsysbio.org\/navargator."},{"key":"1054_CR23","doi-asserted-by":"publisher","unstructured":"Curran, D. M. et al. Phylogeny-based selection of representative variants with Navargator: proof of principle using humoral cross-reactivity data from two immunization studies. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.09.08.611914 (2024).","DOI":"10.1101\/2024.09.08.611914"},{"key":"1054_CR24","doi-asserted-by":"publisher","first-page":"113037","DOI":"10.1016\/j.jim.2021.113037","volume":"493","author":"JE Fegan","year":"2021","unstructured":"Fegan, J. E., Yu, R. H., Islam, E. A. & Schryvers, A. B. Development of a non-biased, high-throughput ELISA for the rapid evaluation of immunogenicity and cross-reactivity. J. Immunol. Methods 493, 113037 (2021).","journal-title":"J. Immunol. Methods"},{"key":"1054_CR25","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1128\/IAI.02572-14","volume":"83","author":"R Frandoloso","year":"2015","unstructured":"Frandoloso, R. et al. Nonbinding site-directed mutants of transferrin binding protein B enhances their immunogenicity and protective capabilities. Infect. Immun. 83, 1030\u20131038 (2015).","journal-title":"Infect. Immun."},{"key":"1054_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25685-1","volume":"8","author":"JA Guizzo","year":"2018","unstructured":"Guizzo, J. A. et al. The amino acid selected for generating mutant TbpB antigens defective in binding transferrin can compromise the in vivo protective capacity. Sci. Rep. 8, 7372 (2018).","journal-title":"Sci. Rep."},{"key":"1054_CR27","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/j.1365-2958.1988.tb00095.x","volume":"2","author":"BC Lee","year":"1988","unstructured":"Lee, B. C. & Schryvers, A. B. Specificity of the lactoferrin and transferrin receptors in Neisseria gonorrhoeae. Mol. Microbiol. 2, 827\u2013829 (1988).","journal-title":"Mol. Microbiol."},{"key":"1054_CR28","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1093\/jac\/dkw288","volume":"71","author":"M Unemo","year":"2016","unstructured":"Unemo, M. et al. The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization. J. Antimicrob. Chemother. 71, 3096\u20133108 (2016).","journal-title":"J. Antimicrob. Chemother."},{"key":"1054_CR29","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1128\/JB.181.18.5591-5599.1999","volume":"181","author":"TC Fudyk","year":"1999","unstructured":"Fudyk, T. C. et al. Genetic diversity and mosaicism at the por locus of Neisseria gonorrhoeae. J. Bacteriol. 181, 5591\u20135599 (1999).","journal-title":"J. Bacteriol."},{"key":"1054_CR30","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1002\/1873-3468.13760","volume":"594","author":"LA Lewis","year":"2020","unstructured":"Lewis, L. A. & Ram, S. Complement interactions with the pathogenic Neisseriae: clinical features, deficiency states, and evasion mechanisms. FEBS Lett. 594, 2670\u20132694 (2020).","journal-title":"FEBS Lett."},{"key":"1054_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1128\/IAI.00711-09","volume":"78","author":"M Packiam","year":"2010","unstructured":"Packiam, M., Veit, S. J., Anderson, D. J., Ingalls, R. R. & Jerse, A. E. Mouse strain-dependent differences in susceptibility to Neisseria gonorrhoeae infection and induction of innate immune responses. Infect. Immun. 78, 433\u2013440 (2010).","journal-title":"Infect. Immun."},{"key":"1054_CR32","doi-asserted-by":"publisher","unstructured":"Currie, E. G. et al. Protection against Neisseria meningitidis nasopharyngeal colonization relies on antibody opsonization and phagocytosis by neutrophils. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.09.11.612551 (2024).","DOI":"10.1101\/2024.09.11.612551"},{"key":"1054_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/14760584.2018.1483726","volume":"17","author":"JL Perez","year":"2018","unstructured":"Perez, J. L. et al. From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine. Expert Rev. Vaccines 17, 461\u2013477 (2018).","journal-title":"Expert Rev. Vaccines"},{"key":"1054_CR34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0966-842X(00)01771-6","volume":"8","author":"O Billker","year":"2000","unstructured":"Billker, O., Popp, A., Gray-Owen, S. D. & Meyer, T. F. The structural basis of CEACAM-receptor targeting by neisserial Opa proteins. Trends Microbiol. 8, 258\u2013260 (2000).","journal-title":"Trends Microbiol."},{"key":"1054_CR35","doi-asserted-by":"publisher","first-page":"22235","DOI":"10.1074\/jbc.M111.225516","volume":"286","author":"J Shaughnessy","year":"2011","unstructured":"Shaughnessy, J. et al. Molecular characterization of the interaction between sialylated Neisseria gonorrhoeae and factor H. J. Biol. Chem. 286, 22235\u201322242 (2011).","journal-title":"J. Biol. Chem."},{"key":"1054_CR36","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1567-5769(00)00037-0","volume":"1","author":"S Ram","year":"2001","unstructured":"Ram, S. et al. C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae. Int. Immunopharmacol. 1, 423\u2013432 (2001).","journal-title":"Int. Immunopharmacol."},{"key":"1054_CR37","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/j.1460-2075.1984.tb02016.x","volume":"3","author":"J Pohlner","year":"1984","unstructured":"Pohlner, J., Halter, R. & Meyer, T. F. IgA protease of Neisseria gonorrhoeae: isolation and characterization of the gene and its extracellular product. EMBO J. 3, 1595\u20131601 (1984).","journal-title":"EMBO J."},{"key":"1054_CR38","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1128\/IAI.00072-07","volume":"75","author":"AJ DeRocco","year":"2007","unstructured":"DeRocco, A. J. & Cornelissen, C. N. Identification of transferrin-binding domains in TbpB expressed by Neisseria gonorrhoeae. Infect. Immun. 75, 3220\u20133232 (2007).","journal-title":"Infect. Immun."},{"key":"1054_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jsb.2013.02.009","volume":"184","author":"N Noinaj","year":"2013","unstructured":"Noinaj, N., Cornelissen, C. N. & Buchanan, S. K. Structural insight into the lactoferrin receptors from pathogenic Neisseria. J. Struct. Biol. 184, 83\u201392 (2013).","journal-title":"J. Struct. Biol."},{"key":"1054_CR40","doi-asserted-by":"publisher","first-page":"e00949","DOI":"10.1128\/mBio.00949-20","volume":"11","author":"MT Kammerman","year":"2020","unstructured":"Kammerman, M. T. et al. Molecular insight into TdfH-Mediated Zinc piracy from human calprotectin by Neisseria gonorrhoeae. mBio 11, e00949\u201300920 (2020).","journal-title":"mBio"},{"key":"1054_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007937","volume":"15","author":"S Maurakis","year":"2019","unstructured":"Maurakis, S. et al. The novel interaction between Neisseria gonorrhoeae TdfJ and human S100A7 allows gonococci to subvert host zinc restriction. PLoS Pathog. 15, e1007937 (2019).","journal-title":"PLoS Pathog."},{"key":"1054_CR42","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.4049\/jimmunol.1003470","volume":"186","author":"PT Beernink","year":"2011","unstructured":"Beernink, P. T. et al. A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination. J. Immunol. 186, 3606\u20133614 (2011).","journal-title":"J. Immunol."},{"key":"1054_CR43","doi-asserted-by":"publisher","first-page":"e00095","DOI":"10.1128\/mBio.00095-11","volume":"2","author":"Y Liu","year":"2011","unstructured":"Liu, Y. & Russell, M. W. Diversion of the immune response to Neisseria gonorrhoeae from Th17 to Th1\/Th2 by treatment with anti-transforming growth factor \u03b2 antibody generates immunological memory and protective immunity. mBio 2, e00095\u201300011 (2011).","journal-title":"mBio"},{"key":"1054_CR44","doi-asserted-by":"publisher","unstructured":"Islam E. A. et al. Adjuvant-dependent impacts on vaccine-induced humoral correlates of protection in preclinical models of nasal and genital colonization by the pathogenic Neisseria. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.09.07.611809 (2024).","DOI":"10.1101\/2024.09.07.611809"},{"key":"1054_CR45","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772\u2013780 (2013).","journal-title":"Mol. Biol. Evol."},{"key":"1054_CR46","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/bioinformatics\/btu033","volume":"30","author":"A Stamatakis","year":"2014","unstructured":"Stamatakis, A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30, 1312\u20131313 (2014).","journal-title":"Bioinformatics"},{"key":"1054_CR47","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2144\/000113418","volume":"48","author":"AV Bryksin","year":"2010","unstructured":"Bryksin, A. V. & Matsumura, I. Overlap extension PCR cloning: a simple and reliable way to create recombinant plasmids. Biotechniques 48, 463\u2013465 (2010).","journal-title":"Biotechniques"},{"key":"1054_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","volume":"41","author":"FW Studier","year":"2005","unstructured":"Studier, F. W. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41, 207\u2013234 (2005).","journal-title":"Protein Expr. Purif."},{"key":"1054_CR49","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1128\/IAI.03123-14","volume":"83","author":"A Sintsova","year":"2015","unstructured":"Sintsova, A. et al. Selection for a CEACAM receptor-specific binding phenotype during Neisseria gonorrhoeae infection of the human genital tract. Infect. Immun. 83, 1372\u20131383 (2015).","journal-title":"Infect. Immun."},{"key":"1054_CR50","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1128\/IAI.67.11.5699-5708.1999","volume":"67","author":"AE Jerse","year":"1999","unstructured":"Jerse, A. E. Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect. Immun. 67, 5699\u20135708 (1999).","journal-title":"Infect. Immun."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-01054-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-01054-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-01054-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:53:45Z","timestamp":1736902425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-01054-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1054"],"URL":"https:\/\/doi.org\/10.1038\/s41541-024-01054-0","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"7 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: J.E.F., E.A.I., D.M.C., D.N., N.A., A.B.S., T.F.M., and S.D.G. are named inventors on the below patent and patent application which include intellectual property regarding the use of transferrin binding protein B as a vaccine antigen for protection against\n                      N. gonorrhea\n                      : 1. Schryvers, A.B., Moraes, T., and Gray-Owen, S.D. Immunogenic compositions and vaccines derived from bacterial surface receptor proteins. International Patent Application PCT\/CA2014\/051146. Filed December 1, 2014. PCT National Phase Filings in: US, Canada, Europe, China, Australia, Japan, India, Brazil, New Zealand, Eurasia, South Korea. US Patent #10149900B2 issued December 11, 2018. Australian Patent 2014360590 was granted on August 28, 2019. Eurasian Patent 201691140 was granted on April 4, 2021. New Zealand Patent 721121 was granted on December 1, 2021. European Patent #3077512 was granted on February 9, 2022. South Korea patent #10-2507993 was granted on March 6, 2023. India Patent #424510 was granted on March 9, 2023. 2. Fegan, J., Islam, E., Curran, D., Ng, D., Au, N., Schryvers, A.B., Moraes, T.F. and Gray-Owen, S.D. Vaccines and methods for the treatment of Neisseria gonorrhoeae infections. US Patent and Trademark Office #63\/691,519, filed September 6, 2024. All other authors (E.G.C., J.J.Z., and J.L.) declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}